Status:
COMPLETED
Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild Asthmatics
Lead Sponsor:
Medical University of Lodz
Collaborating Sponsors:
Ministry of Science and Higher Education, Poland
Conditions:
Bronchial Asthma
Eligibility:
All Genders
22-56 years
Phase:
PHASE1
Brief Summary
The aim of the study is to investigate the effect of inhaled apocynin on ROS (reactive oxygen species) and NOS (reactive nitrogen species) synthesis in 10 nonsmoking mild asthmatics. Effects of nebuli...
Detailed Description
The study had a double-blind, placebo-controlled, cross-over design, consisted of 2 visits, separated 30 ± 10 days. If during the first visit the drug was used, in the second visit - placebo or vice v...
Eligibility Criteria
Inclusion
- patients suffering from bronchial asthma (mild)
- patients free of any medication at least 7 days before research
- patients had not suffered from any infectious diseases including upper respiratory tract infections for at least 3 months prior to the study
Exclusion
- patients suffering from moderate or severe asthma
- patients taking medication 7 or less days before the study
- infectious diseases that had occurred 3 months or less before the study
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00992667
Start Date
June 1 2008
End Date
November 1 2008
Last Update
October 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Lodz
Lodz, Łódź Voivodeship, Poland, 92-213